8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jan 25, 2007)

Filed January 25, 2007For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K report on January 25, 2007, to announce its financial results for the fourth quarter and full year ended December 31, 2006. This filing serves as a key disclosure for investors to understand the company's recent performance. While the 8-K itself primarily references an attached press release (Exhibit 99.1) for the detailed financial information, the core purpose is to disseminate these operational and financial outcomes promptly. Investors should refer to the press release referenced in the filing for specific figures on revenue, earnings per share, and other key financial metrics for the period. The report confirms that Quest Diagnostics has met its reporting obligation to inform the market about its financial condition and results of operations for the concluded fiscal year and quarter.

Key Highlights

  • 1Quest Diagnostics filed an 8-K on January 25, 2007.
  • 2The filing reports on the company's financial results for the quarter and twelve months ended December 31, 2006.
  • 3The detailed financial information is provided in an attached press release (Exhibit 99.1), which is incorporated by reference.
  • 4This 8-K is primarily an announcement of financial results, falling under Item 2.02 (Results of Operations and Financial Condition).
  • 5The report includes the required financial statements and exhibits as per Item 9.01.
  • 6The filing was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer, indicating official corporate authorization.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce Quest Diagnostics Incorporated's financial results for the fourth quarter and the full fiscal year ended December 31, 2006. This is a regulatory requirement for publicly traded companies to promptly inform investors of significant financial developments.

The detailed financial results are not fully presented within the 8-K document itself. Instead, they are provided in a press release dated January 25, 2007, which is attached as Exhibit 99.1 to this 8-K filing and incorporated by reference.

Investors should look for key performance indicators such as revenue, net income, earnings per share (EPS) for both the quarter and the full year, as well as any commentary on the company's financial condition, operational performance, and outlook provided by management in the press release.

Robert A. Hagemann is the Senior Vice President and Chief Financial Officer of Quest Diagnostics. His signature on the 8-K report signifies that the company has officially reviewed and authorized the information being disclosed to the Securities and Exchange Commission and the investing public.